On the public citation graph

NAFLD: Reporting Histologic Findings in Clinical Practice

0 signed · 212 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jamanetworkopen.2019.12565openalex-snapshot
Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1002/hep.20701openalex-snapshot
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
inferredcites →https://doi.org/10.1002/hep.20842openalex-snapshot
Histopathology of Pediatric Nonalcoholic Fatty Liver Disease * #
inferredcites →https://doi.org/10.1002/hep.23719openalex-snapshot
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1002/hep.24127openalex-snapshot
Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings §Δ
inferredcites →https://doi.org/10.1002/hep.25559openalex-snapshot
Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1002/hep.25889openalex-snapshot
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
inferredcites →https://doi.org/10.1002/hep.27173openalex-snapshot
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1002/hep.27368openalex-snapshot
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
inferredcites →https://doi.org/10.1002/hep.28785openalex-snapshot
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
inferredcites →https://doi.org/10.1002/hep.29085openalex-snapshot
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
inferredcites →https://doi.org/10.1002/hep.29607openalex-snapshot
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
inferredcites →https://doi.org/10.1002/hep.30418openalex-snapshot
Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials
inferredcites →https://doi.org/10.1002/hep.30672openalex-snapshot
Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum
inferredcites →https://doi.org/10.1002/hep.30782openalex-snapshot
Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD
inferredcites →https://doi.org/10.1002/hep.510290347openalex-snapshot
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
inferredcites →https://doi.org/10.1016/j.cgh.2017.02.030openalex-snapshot
In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis
inferredcites →https://doi.org/10.1016/j.cld.2009.07.008openalex-snapshot
Histopathology of Non-Alcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1016/j.cmet.2019.12.002openalex-snapshot
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
inferredcites →https://doi.org/10.1016/j.dld.2019.12.121openalex-snapshot
The economic cost and health burden of non-alcoholic steatohepatitis in the EU5 countries
inferredcites →https://doi.org/10.1016/j.ejim.2005.06.010openalex-snapshot
Safety and efficacy of percutaneous CT-guided liver biopsy using an 18-gauge automated needle
inferredcites →https://doi.org/10.1016/j.hepres.2005.09.016openalex-snapshot
Histological study on comparison between NASH and ALD
inferredcites →https://doi.org/10.1016/j.humpath.2011.07.007openalex-snapshot
Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.jhep.2008.01.026openalex-snapshot
Ballooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosis
inferredcites →https://doi.org/10.1016/j.jhep.2011.05.019openalex-snapshot
Lipotoxicity in NASH
inferredcites →https://doi.org/10.1016/j.jhep.2017.10.015openalex-snapshot
Pharmacotherapy for NASH: Current and emerging
inferredcites →https://doi.org/10.1016/j.jhep.2017.11.014openalex-snapshot
Lipotoxicity and the gut-liver axis in NASH pathogenesis
inferredcites →https://doi.org/10.1016/j.jhep.2019.04.019openalex-snapshot
Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD
inferredcites →https://doi.org/10.1016/j.metabol.2016.02.014openalex-snapshot
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/s0002-9270(99)00433-5openalex-snapshot
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
inferredcites →https://doi.org/10.1016/s0016-5085(82)80007-3openalex-snapshot
Occlusive Venous Lesions in Alcoholic Liver Disease
inferredcites →https://doi.org/10.1016/s0025-6196(24)00530-5openalex-snapshot
Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1016/s1665-2681(19)31748-xopenalex-snapshot
NASH and cryptogenic cirrhosis: A histological analysis
inferredcites →https://doi.org/10.1021/acs.jmedchem.9b01701openalex-snapshot
The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease
inferredcites →https://doi.org/10.1038/nrd.2015.3openalex-snapshot
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
inferredcites →https://doi.org/10.1038/s41575-019-0144-8openalex-snapshot
Past, present and future perspectives in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1038/s41591-018-0104-9openalex-snapshot
Mechanisms of NAFLD development and therapeutic strategies
inferredcites →https://doi.org/10.1053/j.gastro.2005.03.084openalex-snapshot
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1053/j.gastro.2012.02.003openalex-snapshot
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
inferredcites →https://doi.org/10.1053/j.gastro.2014.01.018openalex-snapshot
A Histologic Scoring System for Prognosis of Patients With Alcoholic Hepatitis
inferredcites →https://doi.org/10.1053/j.gastro.2015.04.043openalex-snapshot
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1053/j.gastro.2016.02.066openalex-snapshot
Pathogenesis of Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1053/j.gastro.2018.04.014openalex-snapshot
Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1053/j.gastro.2018.06.031openalex-snapshot
Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1053/j.gastro.2018.12.036openalex-snapshot
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1053/j.gastro.2020.01.051openalex-snapshot
Therapeutic Landscape for NAFLD in 2020
inferredcites →https://doi.org/10.1053/j.gastro.2020.04.039openalex-snapshot
Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum
inferredcites →https://doi.org/10.1055/s-0032-1306421openalex-snapshot
Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research
inferredcites →https://doi.org/10.1097/00004836-199503000-00011openalex-snapshot
Two Cases from the Spectrum of Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1097/01.mp.0000042420.21088.c7openalex-snapshot
Concurrence of Histologic Features of Steatohepatitis with Other Forms of Chronic Liver Disease
inferredcites →https://doi.org/10.1097/mpg.0000000000001482openalex-snapshot
NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children
inferredcites →https://doi.org/10.1111/j.1365-2036.2007.03425.xopenalex-snapshot
Histological progression of non‐alcoholic fatty liver disease: a critical reassessment based on liver sampling variability
inferredcites →https://doi.org/10.1146/annurev-pathol-012615-044224openalex-snapshot
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
inferredcites →https://doi.org/10.1177/1756283x15611581openalex-snapshot
Practice patterns in NAFLD and NASH: real life differs from published guidelines
inferredcites →https://doi.org/10.1194/jlr.r066357openalex-snapshot
Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
inferredcites →https://doi.org/10.2337/dc19-1113openalex-snapshot
Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S.
inferredcites →https://doi.org/10.3109/00365521.2011.634024openalex-snapshot
Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression
inferredcites →https://doi.org/10.3748/wjg.v16.i42.5286openalex-snapshot
Histopathology of nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.5152/dir.2018.17525openalex-snapshot
Predictors of bleeding complications following percutaneous image-guided liver biopsy: a scoping review
inferredcites →https://doi.org/10.7326/0003-4819-59-5-646openalex-snapshot
Sclerosing Hyaline Necrosis of the Liver in the Chronic Alcoholic

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4841348openalex-extracted
Zuogui-Jiangtang-Qinggan Formula Alleviated Hepatic Steatosis in Diabetes by Improving Energy and Bile Acid Metabolism: Based on Multi-Omics Integration Studies
inferred← citeshttps://doi.org/10.1002/ame2.12338openalex-snapshot
Hepatic transcriptome signatures in mice and humans with nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1002/hep.31897openalex-snapshot
A Systematic Review of Animal Models of NAFLD Finds High‐Fat, High‐Fructose Diets Most Closely Resemble Human NAFLD
inferred← citeshttps://doi.org/10.1002/jpn3.70490openalex-snapshot
European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) steatotic liver disease special interest group position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction‐associated steatotic liver disease
inferred← citeshttps://doi.org/10.1002/mco2.70448openalex-snapshot
Discovering Heterogeneous Leukocytes Subsets Associated With Alcoholic Steatohepatitis by scRNAseq Analysis
inferred← citeshttps://doi.org/10.1002/psp4.13275openalex-snapshot
Exposure–response modeling of liver fat imaging endpoints in non‐alcoholic fatty liver disease populations administered ervogastat alone and co‐administered with clesacostat
inferred← citeshttps://doi.org/10.1007/978-3-030-84164-5_16openalex-snapshot
Delivery of Oligonucleotide Therapeutics for Macrophage Reprogramming in Inflammatory Diseases
inferred← citeshttps://doi.org/10.1007/978-981-97-9519-2_6openalex-snapshot
Histopathology of MASLD: Insights into Liver Tissue Changes
inferred← citeshttps://doi.org/10.1007/s00261-022-03561-xopenalex-snapshot
Fat in mass in primary liver lesions: are usual MRI diagnostic criteria of both malignant and benign liver lesions still applicable?
inferred← citeshttps://doi.org/10.1007/s00535-026-02507-0openalex-snapshot
Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial
inferred← citeshttps://doi.org/10.1007/s10396-024-01472-6openalex-snapshot
Diagnostic accuracy of ultrasound-derived fat fraction for the detection and quantification of hepatic steatosis in patients with liver biopsy
inferred← citeshttps://doi.org/10.1007/s10620-023-08225-4openalex-snapshot
Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis
inferred← citeshttps://doi.org/10.1007/s11695-021-05797-wopenalex-snapshot
Routine Versus Selective Liver Biopsy During Bariatric Surgery: Postoperative Outcomes and Preoperative Predictors of NASH
inferred← citeshttps://doi.org/10.1007/s11695-022-06380-7openalex-snapshot
Reliability of Non-invasive Liver Fibrosis Assessment Tools Versus Biopsy in Pre- and Post-bariatric Surgery Patients with Non-alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/s11695-023-06568-5openalex-snapshot
Application of Scores Assessing Histological Activity and Estimated Long-Term Risk Analysis of Hepatic Decompensation of Non-Alcoholic Fatty Liver Disease in Individuals Undergoing Bariatric Surgery
inferred← citeshttps://doi.org/10.1007/s11695-023-06998-1openalex-snapshot
Fibrotic NASH in Individuals with Obesity: a Cross-sectional Analysis of the Prevalence of this Significant Milestone of Disease Progression and Accuracy of a Non-invasive Marker for its Screening
inferred← citeshttps://doi.org/10.1007/s11695-024-07180-xopenalex-snapshot
Association of Histopathological and Biochemical Aspects of NAFLD With the Severity of Liver Fibrosis in Individuals With Obesity: Cross-sectional Study
inferred← citeshttps://doi.org/10.1007/s11695-025-07688-wopenalex-snapshot
Short-Term Evolution of MASLD Following Roux-en-Y Gastric Bypass: A Focus on Fibrotic MASH
inferred← citeshttps://doi.org/10.1007/s11739-025-04090-3openalex-snapshot
Tango between obesogenic environment and metabolic dysfunction-associated steatotic liver disease (MASLD): shifting towards earlier detection
inferred← citeshttps://doi.org/10.1007/s11892-024-01558-yopenalex-snapshot
NAFLD No More: A Review of Current Guidelines in the Diagnosis and Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
inferred← citeshttps://doi.org/10.1007/s12072-023-10590-1openalex-snapshot
How non-alcoholic fatty liver disease and cirrhosis affect the heart
inferred← citeshttps://doi.org/10.1016/b978-0-323-99136-0.00014-3openalex-snapshot
Artificial intelligence in pathology and application to liver disease
inferred← citeshttps://doi.org/10.1016/b978-0-323-99649-5.00003-0openalex-snapshot
Clinical diagnosis and evaluation pathway
inferred← citeshttps://doi.org/10.1016/b978-0-323-99649-5.00014-5openalex-snapshot
Natural history of nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/b978-0-7020-8228-3.00005-3openalex-snapshot
Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/b978-0-7020-8228-3.00006-5openalex-snapshot
Hepatitis Due to Hepatotropic Viruses
inferred← citeshttps://doi.org/10.1016/j.actbio.2024.06.014openalex-snapshot
Nanoformulations for the diagnosis and treatment of metabolic dysfunction-associated steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.addr.2021.113869openalex-snapshot
Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis
inferred← citeshttps://doi.org/10.1016/j.ajg.2024.02.003openalex-snapshot
Dietary composition and its association with metabolic dysfunction-associated fatty liver disease among Chinese adults: A cross-sectional study
inferred← citeshttps://doi.org/10.1016/j.apsb.2021.03.018openalex-snapshot
Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.cgh.2021.12.002openalex-snapshot
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
inferred← citeshttps://doi.org/10.1016/j.cld.2022.05.001openalex-snapshot
Nonalcoholic Steatohepatitis in Children
inferred← citeshttps://doi.org/10.1016/j.cld.2023.01.017openalex-snapshot
Role of Liver Biopsy in Clinical Trials and Clinical Management of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/j.clnesp.2025.09.021openalex-snapshot
Novel surrogate markers of insulin resistance in patients with metabolic dysfunction-associated steatosis liver disease: Associations with dietary and lifestyle inflammatory scores in the large cross-sectional study
inferred← citeshttps://doi.org/10.1016/j.dld.2022.02.009openalex-snapshot
Ubiquitin-specific peptidase 10 ameliorates hepatic steatosis in nonalcoholic steatohepatitis model by restoring autophagic activity
inferred← citeshttps://doi.org/10.1016/j.ebiom.2023.104543openalex-snapshot
Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.etap.2025.104773openalex-snapshot
The dithiocarbamate pesticides maneb and mancozeb disturb the metabolism of lipids and xenobiotics in an in vitro model of metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.1016/j.humpath.2022.06.019openalex-snapshot
The many faces and pathologic diagnostic challenges of autoimmune hepatitis
inferred← citeshttps://doi.org/10.1016/j.humpath.2026.106112openalex-snapshot
The evolving landscape of pathologic interpretation in metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.1016/j.jceh.2021.08.002openalex-snapshot
Magnetic Resonance Elastography for the Clinical Risk Assessment of Fibrosis, Cirrhosis, and Portal Hypertension in Patients With NAFLD
inferred← citeshttps://doi.org/10.1016/j.jceh.2023.07.003openalex-snapshot
NAFLD: Diagnostics and New Nomenclature
inferred← citeshttps://doi.org/10.1016/j.jcmgh.2026.101866openalex-snapshot
Thermoneutrality Accelerates a Distinctive Metabolic Dysfunction–Associated Steatohepatitis Phenotype in a Diet-Induced Male Mouse Model With Similarities to Human Disease
inferred← citeshttps://doi.org/10.1016/j.jep.2025.119862openalex-snapshot
Trigonella foenum-graecum L. ameliorates metabolism-associated fatty liver disease in type 2 diabetic mice: a multi-omics mechanism analysis
inferred← citeshttps://doi.org/10.1016/j.jff.2026.107311openalex-snapshot
Hepatoprotective effects of pentadecanoic acid-rich microalgae Melosira nummuloides in a high-fat diet-induced mouse model of non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.jhep.2022.09.021openalex-snapshot
Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and cons
inferred← citeshttps://doi.org/10.1016/j.jhepr.2023.100778openalex-snapshot
Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.jhepr.2025.101470openalex-snapshot
Autoantibodies are associated with worse outcomes in MASLD
inferred← citeshttps://doi.org/10.1016/j.jhepr.2026.101737openalex-snapshot
The Elucidating Pathways of Steatohepatitis (EPoS) staging system: A reproducible 7-tiered fibrosis scoring system in MASLD
inferred← citeshttps://doi.org/10.1016/j.jlr.2021.100134openalex-snapshot
Low production of 12α-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70−/− mice by reducing fat absorption
inferred← citeshttps://doi.org/10.1016/j.lfs.2022.120634openalex-snapshot
Protective effects of maslinic acid on high fat diet-induced liver injury in mice
inferred← citeshttps://doi.org/10.1016/j.mad.2025.112122openalex-snapshot
Diminished CEACAM1 level plays a critical role in age-related hepatic fibrosis
inferred← citeshttps://doi.org/10.1016/j.maturitas.2021.06.012openalex-snapshot
The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause
inferred← citeshttps://doi.org/10.1016/j.mayocp.2022.04.005openalex-snapshot
Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
inferred← citeshttps://doi.org/10.1016/j.metabol.2024.156063openalex-snapshot
Serum lipidomic signatures in patients with varying histological severity of metabolic-dysfunction associated steatotic liver disease
inferred← citeshttps://doi.org/10.1016/j.metop.2021.100158openalex-snapshot
Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]
inferred← citeshttps://doi.org/10.1016/j.mmm.2023.03.006openalex-snapshot
NAFLD et dysfonction mitochondriale
inferred← citeshttps://doi.org/10.1016/j.molmet.2024.102010openalex-snapshot
Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation
inferred← citeshttps://doi.org/10.1016/j.molstruc.2024.140755openalex-snapshot
Garcibracgluinols A-C, structurally intriguing polycyclic polyprenylated acylphloroglucinols from Garcinia bracteata alleviate hepatocyte lipid accumulation and insulin resistance
inferred← citeshttps://doi.org/10.1016/j.pathol.2022.01.009openalex-snapshot
Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.phrs.2023.106925openalex-snapshot
Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development
inferred← citeshttps://doi.org/10.1016/j.phymed.2022.154576openalex-snapshot
Integrative multi-omics unravels the amelioration effects of Zanthoxylum bungeanum Maxim. on non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.phymed.2026.158128openalex-snapshot
Integrated analysis of network pharmacology and multi-omics reveals the mechanisms of Zuogui Jiangtang Qinggan formula ameliorates MASLD via fatty acid metabolic reprogramming
inferred← citeshttps://doi.org/10.1016/j.ultrasmedbio.2025.06.011openalex-snapshot
Multiparametric ultrasound evaluation of metabolic dysfunction-associated fatty liver disease in minipigs
inferred← citeshttps://doi.org/10.1016/s1875-5364(24)60690-4openalex-snapshot
Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.5c00157openalex-snapshot
Flavonoid–Sesquiterpenoid Hybrids from the Leaves of Syzygium simile and Their Anti-Lipid Droplet Accumulation Activities
inferred← citeshttps://doi.org/10.1021/acs.jproteome.5c00768openalex-snapshot
Combined UHPLC with MALDI-MS Imaging Reveals Hepatic Lipid Metabolism Homeostasis in Tetrabromobisphenol A-Exposed Mice
inferred← citeshttps://doi.org/10.1038/s41390-022-02032-9openalex-snapshot
LncOb rs10487505 variant is associated with leptin levels in pediatric non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1038/s41575-025-01120-5openalex-snapshot
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease
inferred← citeshttps://doi.org/10.1038/s41598-022-22902-wopenalex-snapshot
Automated whole slide image analysis for a translational quantification of liver fibrosis
inferred← citeshttps://doi.org/10.1038/s41598-022-25931-7openalex-snapshot
Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1038/s42255-022-00700-yopenalex-snapshot
A researcher’s guide to preclinical mouse NASH models
inferred← citeshttps://doi.org/10.1038/s44355-025-00027-xopenalex-snapshot
Specific clinicopathologic findings are associated with the severity and chronicity of drug-induced liver injury among hospitalized patients
inferred← citeshttps://doi.org/10.1042/cs20210628openalex-snapshot
Exposure to cigarette smoke precipitates simple hepatosteatosis to NASH in high-fat diet fed mice by inducing oxidative stress
inferred← citeshttps://doi.org/10.1053/j.gastro.2022.06.023openalex-snapshot
AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review
inferred← citeshttps://doi.org/10.1056/nejmoa2413258openalex-snapshot
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
inferred← citeshttps://doi.org/10.1093/ije/dyag101openalex-snapshot
Cohort Profile Update: The Finnish Gestational Diabetes (FinnGeDi) study
inferred← citeshttps://doi.org/10.1097/cm9.0000000000002156openalex-snapshot
Bile acids and sphingolipids in non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000392openalex-snapshot
Granulomatous liver diseases
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000586openalex-snapshot
Serum protein risk stratification score for diagnostic evaluation of metabolic dysfunction–associated steatohepatitis
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000931openalex-snapshot
Multi-threshold analysis of the ELF Test versus histology for prognostication of disease progression and regression in MASH
inferred← citeshttps://doi.org/10.1097/hep.0000000000000323openalex-snapshot
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1097/hep.0000000000000780openalex-snapshot
Genomics of human NAFLD: Lack of data reproducibility and high interpatient variability in drug target expression as major causes of drug failures
inferred← citeshttps://doi.org/10.1097/hep.0000000000001318openalex-snapshot
Proton density fat fraction for diagnosis of metabolic dysfunction–associated steatotic liver disease
inferred← citeshttps://doi.org/10.1097/mcg.0000000000001780openalex-snapshot
Expert Panel Consensus on Clinical Assertion Statements Describing Noninvasive Tools for Diagnosing Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1097/md.0000000000042078openalex-snapshot
Influence of triglycerides on the link between gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease in nonobese Chinese adults: A secondary cohort study
inferred← citeshttps://doi.org/10.1097/meg.0000000000003067openalex-snapshot
Prevalence and risk factors of metabolic dysfunction–associated steatotic liver disease in patients with inflammatory bowel disease
inferred← citeshttps://doi.org/10.1097/meg.0000000000003076openalex-snapshot
Histological disease progression in patients with metabolic dysfunction–associated steatotic liver disease using paired liver biopsy
inferred← citeshttps://doi.org/10.1097/pap.0000000000000483openalex-snapshot
Steatotic Liver Disease: Navigating Pathologic Features, Diagnostic Challenges, and Emerging Insights
inferred← citeshttps://doi.org/10.1101/2020.12.15.422799openalex-snapshot
A systematic analysis of rodent models implicates adipogenesis and innate immunity in pathogenesis of fatty liver disease
inferred← citeshttps://doi.org/10.1101/2022.03.17.22272494openalex-snapshot
Bone morphogenetic protein 2 is a new molecular target linked to nonalcoholic fatty liver disease with potential value as non-invasive screening tool
inferred← citeshttps://doi.org/10.1101/2024.04.02.586238openalex-snapshot
Conditional deletion of CEACAM1 causes hepatic stellate cell activation
inferred← citeshttps://doi.org/10.1111/apt.16674openalex-snapshot
Liver biopsy in the real world—reporting, expert concordance and correlation with a pragmatic clinical diagnosis
inferred← citeshttps://doi.org/10.1111/apt.16794openalex-snapshot
Review article: role of glucagon‐like peptide‐1 receptor agonists in non‐alcoholic steatohepatitis, obesity and diabetes—what hepatologists need to know
inferred← citeshttps://doi.org/10.1111/apt.17995openalex-snapshot
Hepatic inflammation and fibrosis are profiles related to mid‐term mortality in biopsy‐proven MASLD: A multicenter study in Japan
inferred← citeshttps://doi.org/10.1111/ijpo.70037openalex-snapshot
Metabolic Dysfunction‐Associated Steatotic Liver Disease in an Urban Paediatric Cohort With High Socioeconomic Deprivation
inferred← citeshttps://doi.org/10.1111/jcmm.70817openalex-snapshot
A Comparison of Novel Serum Markers of Liver Health in Adolescents With Metabolic Dysfunction‐Associated Steatotic Liver Disease
inferred← citeshttps://doi.org/10.1111/nyas.15012openalex-snapshot
Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies
inferred← citeshttps://doi.org/10.1136/gutjnl-2020-323202openalex-snapshot
From the origin of NASH to the future of metabolic fatty liver disease
inferred← citeshttps://doi.org/10.1136/gutjnl-2024-333171openalex-snapshot
British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis
inferred← citeshttps://doi.org/10.1136/jclinpath-2021-207967openalex-snapshot
Improved pathology reporting in NAFLD/NASH for clinical trials
inferred← citeshttps://doi.org/10.1136/jclinpath-2022-208246openalex-snapshot
Paediatric non-alcoholic fatty liver disease: an approach to pathological evaluation
inferred← citeshttps://doi.org/10.1152/ajpendo.00401.2024openalex-snapshot
The evolution of steatosis and fibrosis in mice on a MASH-inducing diet and the effects of housing temperature
inferred← citeshttps://doi.org/10.1177/17562848241276334openalex-snapshot
Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques
inferred← citeshttps://doi.org/10.1186/s13063-023-07444-4openalex-snapshot
Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial
inferred← citeshttps://doi.org/10.1186/s40364-022-00383-3openalex-snapshot
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool
inferred← citeshttps://doi.org/10.14309/ajg.0000000000002508openalex-snapshot
A Study of Dietary Patterns Derived by Cluster Analysis and Their Association With Metabolic Dysfunction-Associated Steatotic Liver Disease Severity Among Hispanic Patients
inferred← citeshttps://doi.org/10.14309/ctg.0000000000000912openalex-snapshot
The Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease on Autoimmune Hepatitis Outcomes: A Nationwide Analysis of 2,880 Records
inferred← citeshttps://doi.org/10.1515/jcim-2026-0258openalex-snapshot
Evaluation of hepatoprotective effect of Acacia catechu stem bark extract on high fat and high fructose diet induced metabolic dysfunction-associated steatotic liver disease in experimental animals
inferred← citeshttps://doi.org/10.1590/1516-3180.2022.0663.r1.24042023openalex-snapshot
Impact of pre-operative weight loss on non-alcoholic fatty liver disease histopathology and insulin resistance in individuals undergoing bariatric surgery: a propensity matched cross-sectional comparison
inferred← citeshttps://doi.org/10.1590/s0004-2803.24612023-050openalex-snapshot
DIAGNOSTIC ACCURACY OF THE NON-INVASIVE MARKERS NFLS, NI-NASH-DS, AND FIB-4 FOR ASSESSMENT OF DIFFERENT ASPECTS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN INDIVIDUALS WITH OBESITY: CROSS-SECTIONAL STUDY
inferred← citeshttps://doi.org/10.20517/mtod.2024.48openalex-snapshot
Cell-specific regulation of insulin action and hepatic fibrosis by CEACAM1
inferred← citeshttps://doi.org/10.21037/hbsn-22-26openalex-snapshot
Metabolic abnormalities play a crucial role in non-obese people suffering from non-alcoholic fatty liver disease (NAFLD)
inferred← citeshttps://doi.org/10.2147/dmso.s356882openalex-snapshot
Relationship Between Thyroid Hormone and Liver Steatosis Analysis Parameter in Obese Participants: A Case-Control Study
inferred← citeshttps://doi.org/10.21608/zvjz.2023.192324.1207openalex-snapshot
Non-Alcoholic Fatty Liver Disease (NAFLD): Molecular Mechanism, Pathological Progression and Treatment
inferred← citeshttps://doi.org/10.2174/0127724328371387250606060831openalex-snapshot
Efficacy and Safety of Ezetimibe for Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.2337/db22-0332openalex-snapshot
High-Fat Diet–Induced DeSUMOylation of E4BP4 Promotes Lipid Droplet Biogenesis and Liver Steatosis in Mice
inferred← citeshttps://doi.org/10.2337/db25-1015openalex-snapshot
Ketogenic Diet and Exercise Improve Peripheral Neuropathy in a Mouse Model of Metabolic Syndrome
inferred← citeshttps://doi.org/10.2478/rjim-2023-0011openalex-snapshot
The correlation between Body Mass Index and histological features of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.29254/2077-4214-2026-3-182-205-210openalex-snapshot
MORPHOLOGICAL FEATURES OF LIVER INJURY IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS WITH COMORBID CHRONIC KIDNEY DISEASE
inferred← citeshttps://doi.org/10.2957/kanzo.62.681openalex-snapshot
Issues regarding NAFLD~From the changes and problems in the pathological diagnosis of NASH to the confusion of nomenclature change
inferred← citeshttps://doi.org/10.32074/1591-951x-242openalex-snapshot
Pathology of non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.3350/cmh.2021.0127openalex-snapshot
Recent advances in nonalcoholic fatty liver disease metabolomics
inferred← citeshttps://doi.org/10.3350/cmh.2022.0426openalex-snapshot
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
inferred← citeshttps://doi.org/10.3389/fcvm.2021.805812openalex-snapshot
Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes
inferred← citeshttps://doi.org/10.3389/fmolb.2026.1730023openalex-snapshot
Serum biomarker screening and metabolic profiling analysis of nonalcoholic fatty liver disease patients using untargeted metabolomics and machine learning techniques
inferred← citeshttps://doi.org/10.3389/fphar.2022.842636openalex-snapshot
Platelets in Non-alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.3389/fphar.2025.1640873openalex-snapshot
A critical review of natural products driven correction of bile acid dysregulation: a therapeutic strategy for nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.3389/fphys.2021.710420openalex-snapshot
Metabolic Changes of Hepatocytes in NAFLD
inferred← citeshttps://doi.org/10.3390/cancers15143723openalex-snapshot
NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models
inferred← citeshttps://doi.org/10.3390/foods14061000openalex-snapshot
Pandanus Amaryllifolius Roxb. Polyphenol Extract Alleviates NAFLD via Regulating Gut Microbiota and AMPK/AKT/mTOR Signaling Pathway
inferred← citeshttps://doi.org/10.3390/ijms22147348openalex-snapshot
Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.3390/ijms23020662openalex-snapshot
The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.3390/ijms24108970openalex-snapshot
SIRT2 Deficiency Aggravates Diet-Induced Nonalcoholic Fatty Liver Disease through Modulating Gut Microbiota and Metabolites
inferred← citeshttps://doi.org/10.3390/ijms241713332openalex-snapshot
Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.3390/ijms26125717openalex-snapshot
Pathogenesis and Clinical Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
inferred← citeshttps://doi.org/10.3390/jcm10132907openalex-snapshot
TSH Levels as an Independent Risk Factor for NAFLD and Liver Fibrosis in the General Population
inferred← citeshttps://doi.org/10.3390/jimaging11100369openalex-snapshot
Preclinical Application of Computer-Aided High-Frequency Ultrasound (HFUS) Imaging: A Preliminary Report on the In Vivo Characterization of Hepatic Steatosis Progression in Mouse Models
inferred← citeshttps://doi.org/10.3390/livers3010003openalex-snapshot
Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review
inferred← citeshttps://doi.org/10.3390/metabo12050431openalex-snapshot
Individuals with Metabolic Syndrome Show Altered Fecal Lipidomic Profiles with No Signs of Intestinal Inflammation or Increased Intestinal Permeability
inferred← citeshttps://doi.org/10.3390/metabo13040536openalex-snapshot
Screening for NAFLD—Current Knowledge and Challenges
inferred← citeshttps://doi.org/10.3390/metabo16080586openalex-snapshot
Therapeutic Mechanisms of Resmetirom and Semaglutide in MASLD/MASH: A Review of Inflammatory and Fibrotic Metabolites
inferred← citeshttps://doi.org/10.3390/nu14183791openalex-snapshot
Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis
inferred← citeshttps://doi.org/10.3390/vetsci10100626openalex-snapshot
Multiple Hepatic Lipoma: A Case Report of Captive Hill Mynah with Iron Storage Disease
inferred← citeshttps://doi.org/10.37349/edd.2023.00034openalex-snapshot
Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative review
inferred← citeshttps://doi.org/10.4254/wjh.v16.i4.511openalex-snapshot
Metabolic dysfunction-associated steatotic liver disease: A silent pandemic
inferred← citeshttps://doi.org/10.4274/dir.2024.242697openalex-snapshot
Assessing hepatic steatosis by magnetic resonance in potential living liver donors
inferred← citeshttps://doi.org/10.52783/jns.v14.3275openalex-snapshot
An Investigation To Look Into The Relationship Between Steatotic Liver Damage And Metabolic Syndrome. Problems: A Thorough Perspective On A Complicated Issue
inferred← citeshttps://doi.org/10.54844/gfm.2023.442openalex-snapshot
Non-alcoholic fatty liver disease: An emerging epidemic of global importance
inferred← citeshttps://doi.org/10.6084/m9.figshare.23826950openalex-snapshot
Additional file 1 of Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial
inferred← citeshttps://doi.org/10.64898/2026.06.04.26354903openalex-snapshot
An integrated proteogenomic investigation of the human liver uncovers molecular drivers of steatotic liver disease
inferred← citeshttps://doi.org/10.70675/ec8920bbza20cz485dzbc51zcc7223270689openalex-snapshot
Stéatopathie métabolique et carcinome hépatocellulaire : prédiction de la carcinogenèse à la réponse au traitement par profilage protéomique
inferred← citeshttps://doi.org/10.7759/cureus.78421openalex-snapshot
Efficacy of Non-invasive Biomarkers in Diagnosing Non-alcoholic Fatty Liver Disease (NAFLD) and Predicting Disease Progression: A Systematic Review
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.